Literature DB >> 18820707

Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis.

H J Kim1, Y M Kim, S Lim, Y K Nam, J Jeong, H-J Kim, K-J Lee.   

Abstract

Ubiquitin C-terminal hydrolase-L1 (UCH-L1) catalyses the hydrolysis of ubiquitin ester and amide mainly in neuronal cells. Recently it was proposed as a marker with a potential role in carcinogenesis. However, the molecular mechanism underlying the biological function of UCH-L1 in tumor cells is poorly understood. We found that UCH-L1 is highly expressed in non-small lung cancer cell line H157, having high invasive potential, and that the expression of UCH-L1 in tumor cells enhances their invasive potential in vitro and in vivo. UCH-L1 changes cell morphology by regulating cell adhesion through Akt-mediated pathway. Suppressing UCH-L1 expression by RNAi significantly suppressed the invasion in vitro and in vivo, and the activation of Akt and downstream mitogen activated protein kinases c-Jun N-terminal kinases and p38, but not ERK. In Akt-negative mutants, overexpression of UCH-L1 does not affect the invasion and migration capability of H157 cells. These results suggest that UCH-L1 is a key molecule to regulate tumor-cell invasion by upstream activation of Akt.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18820707     DOI: 10.1038/onc.2008.364

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  64 in total

1.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells.

Authors:  Nitika Paudel; Sathish Sadagopan; Sandhya Balasubramanian; Bala Chandran
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

2.  Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients.

Authors:  Christine Schröder; Karin Milde-Langosch; Florian Gebauer; Katharina Schmid; Volkmar Mueller; Ralph M Wirtz; Catherine Meyer-Schwesinger; Hartmut Schlüter; Guido Sauter; Udo Schumacher
Journal:  J Cancer Res Clin Oncol       Date:  2013-08-31       Impact factor: 4.553

3.  CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) and P53 mutation pattern in sporadic colorectal cancer.

Authors:  Rania Abdelmaksoud-Dammak; Amena Saadallah-Kallel; Imen Miladi-Abdennadher; Lobna Ayedi; Abdelmajid Khabir; Tahia Sallemi-Boudawara; Mounir Frikha; Jamel Daoud; Raja Mokdad-Gargouri
Journal:  Tumour Biol       Date:  2015-08-28

4.  UCH-L1 promotes invasion of breast cancer cells through activating Akt signaling pathway.

Authors:  Yanhong Luo; Jianfeng He; Chunlin Yang; Matthew Orange; Xingcong Ren; Nick Blair; Tao Tan; Jin-Ming Yang; Hua Zhu
Journal:  J Cell Biochem       Date:  2017-07-31       Impact factor: 4.429

5.  Analysis of the human pancreatic stellate cell secreted proteome.

Authors:  Angela Y Wehr; Emma E Furth; Vineet Sangar; Ian A Blair; Kenneth H Yu
Journal:  Pancreas       Date:  2011-05       Impact factor: 3.327

6.  UCHL1 regulates muscle fibers and mTORC1 activity in skeletal muscle.

Authors:  Hongbo Gao; Jessica Freeling; Penglong Wu; Ashley P Liang; Xuejun Wang; Yifan Li
Journal:  Life Sci       Date:  2019-07-26       Impact factor: 5.037

Review 7.  Proteomic research progress in lymphatic metastases of cancers.

Authors:  Junwei Zong; Chunmei Guo; Shuqing Liu; Ming-Zhong Sun; Jianwu Tang
Journal:  Clin Transl Oncol       Date:  2012-01       Impact factor: 3.405

8.  Ubiquitin C-Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine-Based Inhibitor.

Authors:  Aaron D Krabill; Hao Chen; Sajjad Hussain; Chao Feng; Ammara Abdullah; Chittaranjan Das; Uma K Aryal; Carol Beth Post; Michael K Wendt; Paul J Galardy; Daniel P Flaherty
Journal:  Chembiochem       Date:  2019-11-07       Impact factor: 3.164

9.  Expression and functional studies of ubiquitin C-terminal hydrolase L1 regulated genes.

Authors:  Anjali Bheda; Julia Shackelford; Joseph S Pagano
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

10.  Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma.

Authors:  Barbara Seliger; Diana Handke; Elisabeth Schabel; Juergen Bukur; Rudolf Lichtenfels; Reinhard Dammann
Journal:  J Transl Med       Date:  2009-10-26       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.